Molecular markers involved in tumorigenesis of thyroid carcinoma: focus on aggressive histotypes
GC Penna, F Vaisman, M Vaisman… - … and genome research, 2017 - karger.com
Thyroid cancer derived from follicular cells (TCDFC) comprises well-differentiated (papillary
and follicular) carcinoma, poorly differentiated carcinoma, and anaplastic carcinoma …
and follicular) carcinoma, poorly differentiated carcinoma, and anaplastic carcinoma …
Molecular genetics of thyroid cancer in children and adolescents
AJ Bauer - Endocrinology and Metabolism Clinics, 2017 - endo.theclinics.com
In the simplest approach, thyroid cancer is divided into 2 major categories: follicularderived
tumors, including follicular thyroid carcinoma (FTC) and papillary thyroid carcinoma (PTC) …
tumors, including follicular thyroid carcinoma (FTC) and papillary thyroid carcinoma (PTC) …
[HTML][HTML] Tall cell papillary thyroid carcinoma: new diagnostic criteria and mutations in BRAF and TERT
MS Dettmer, A Schmitt, H Steinert… - Endocrine-related …, 2015 - erc.bioscientifica.com
PDE4 cyclic nucleotide phosphodiesterases regulate cAMP abundance in cells and
therefore regulate numerous processes, including cell growth and differentiation. The rat …
therefore regulate numerous processes, including cell growth and differentiation. The rat …
Prediction of Occult Central Lymph Node Metastasis in Papillary Thyroid Carcinoma by Preoperative BRAF Analysis Using Fine-Needle Aspiration Biopsy: A …
JY Joo, JY Park, YH Yoon, B Choi… - The Journal of …, 2012 - academic.oup.com
Context: Few reports have determined whether preoperative detection of the BRAF V600E
mutation in fine-needle aspiration biopsy (FNAB) may influence determination of surgical …
mutation in fine-needle aspiration biopsy (FNAB) may influence determination of surgical …
[HTML][HTML] Non-coding RNAs: uncharted mediators of thyroid cancer pathogenesis
H Tabatabaeian, S Peiling Yang, Y Tay - Cancers, 2020 - mdpi.com
Simple Summary Thyroid cancer is the most common type of endocrine system malignancy.
The effective diagnosis, precise treatment, and better short and long-term prognosis of …
The effective diagnosis, precise treatment, and better short and long-term prognosis of …
Allele Percentage of the BRAF V600E Mutation in Papillary Thyroid Carcinomas and Corresponding Lymph Node Metastases: No Evidence for a Role in Tumor …
G Gandolfi, V Sancisi, F Torricelli… - The Journal of …, 2013 - academic.oup.com
Context: The relevance of the BRAF V600E mutation in papillary thyroid carcinoma (PTC) as
a negative prognostic factor is a subject of intense debate. This mutation has been …
a negative prognostic factor is a subject of intense debate. This mutation has been …
BRAFV600E mutation does not mean distant metastasis in thyroid papillary carcinomas
V Sancisi, D Nicoli, M Ragazzi, S Piana… - The Journal of …, 2012 - academic.oup.com
Context: The oncogenic BRAFV600E mutation has been frequently associated with
aggressive behavior of papillary thyroid carcinomas. However, controversy exists on the …
aggressive behavior of papillary thyroid carcinomas. However, controversy exists on the …
[HTML][HTML] New therapies for dedifferentiated papillary thyroid cancer
The number of thyroid cancers is increasing. Standard treatment usually includes primary
surgery, thyroid-stimulating hormone suppressive therapy, and ablation of the thyroid …
surgery, thyroid-stimulating hormone suppressive therapy, and ablation of the thyroid …
The BRAFV600E mutation in papillary thyroid microcarcinoma: does the mutation have an impact on clinical outcome?
A Walczyk, A Kowalska, A Kowalik, J Sygut… - Clinical …, 2014 - Wiley Online Library
Context An activating mutation in the gene BRAF has been correlated with poorer prognosis
and more aggressive clinical course in papillary thyroid carcinoma (PTC). We therefore …
and more aggressive clinical course in papillary thyroid carcinoma (PTC). We therefore …